Sterling Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 155 shares of PCRX stock, worth $2,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155Holding current value
$2,549% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
266Shares Held
49.4MCall Options Held
378KPut Options Held
1.43M-
Black Rock Inc. New York, NY8.01MShares$132 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$87.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$81.6 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$33.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$32.6 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $754M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...